Skip to main content

Saurabh Saha

Equibles does not estimate personal net worth.

About Saurabh Saha

Earlier roles on record: CEO and Board Member at Centessa Pharmaceuticals plc (CNTA) until January 1, 2026. Centessa Pharmaceuticals plc reported in an 8-K filed December 11, 2025 that Saurabh Saha resigned as member of the Board, effective January 1, 2026. Centessa Pharmaceuticals plc reported in an 8-K filed December 11, 2025 that Saurabh Saha resigned as Chief Executive Officer, effective January 1, 2026. The proxy statement of Centessa Pharmaceuticals plc reports total compensation of $11,877,244 for Saurabh Saha in fiscal 2025, including a base salary of $683,884. Disclosed compensation is on record for 6 fiscal years.

“On December 5, 2025, Dr. Saurabh Saha, M.D., Ph.D., Chief Executive Officer of the Company notified the Board of his resignation from his positions as Chief Executive Officer and as a member of the Board, effective January 1, 2026 (the "Effective Date").”
Centessa Pharmaceuticals plc Form 8-K, filed December 11, 2025 · Read the filing
“On December 5, 2025, Dr. Saurabh Saha, M.D., Ph.D., Chief Executive Officer of the Company notified the Board of his resignation from his positions as Chief Executive Officer and as a member of the Board, effective January 1, 2026 (the "Effective Date").”
Centessa Pharmaceuticals plc Form 8-K, filed December 11, 2025 · Read the filing

Affiliation history

Company network

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2025 Centessa Pharmaceuticals plc (CNTA) $683,884 $11,877,244
2024 Centessa Pharmaceuticals plc (CNTA) $669,982 $5,563,120
2023 Centessa Pharmaceuticals plc (CNTA) $652,050 $2,705,874
2022 Centessa Pharmaceuticals plc (CNTA) $621,000 $9,612,230
2021 Centessa Pharmaceuticals plc (CNTA) $572,581 $16,068,587
2020 Centessa Pharmaceuticals plc (CNTA) — —

Recent activity